KATHRYN FISHER: Open Payments
NPI 1730917493 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 62 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $485 · 2025 $1,660
Food & beverage: $1,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $308 |
| Ardelyx, Inc. | 4 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $175 |
| Ipsen Biopharmaceuticals, Inc | 2 | $147 |
| Janssen Biotech, Inc. | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Celltrion USA Inc. | 2 | $70 |
| Lilly USA, LLC | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
Products named: IBSRELA, ENTYVIO, SKYRIZI, IQIRVO, RINVOQ, TREMFYA, DUPIXENT, REZDIFFRA.
Industry payments across PA — which companies pay providers there.
